These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21928327)

  • 1. Targeting AMPK in the treatment of malignancies.
    Vakana E; Altman JK; Platanias LC
    J Cell Biochem; 2012 Feb; 113(2):404-9. PubMed ID: 21928327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
    Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as an antitumor agent in cancer prevention and treatment.
    Li D
    J Diabetes; 2011 Dec; 3(4):320-7. PubMed ID: 21631893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells.
    Zakikhani M; Blouin MJ; Piura E; Pollak MN
    Breast Cancer Res Treat; 2010 Aug; 123(1):271-9. PubMed ID: 20135346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
    Rosilio C; Ben-Sahra I; Bost F; Peyron JF
    Cancer Lett; 2014 May; 346(2):188-96. PubMed ID: 24462823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets of metformin antitumor action.
    Sośnicki S; Kapral M; Węglarz L
    Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo anti-melanoma action of metformin.
    Janjetovic K; Harhaji-Trajkovic L; Misirkic-Marjanovic M; Vucicevic L; Stevanovic D; Zogovic N; Sumarac-Dumanovic M; Micic D; Trajkovic V
    Eur J Pharmacol; 2011 Oct; 668(3):373-82. PubMed ID: 21806981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
    Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
    Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor energy pathways for targeted esophagus cancer therapy.
    Shafaee A; Dastyar DZ; Islamian JP; Hatamian M
    Metabolism; 2015 Oct; 64(10):1193-8. PubMed ID: 26271140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy.
    Wang Z; Liu P; Chen Q; Deng S; Liu X; Situ H; Zhong S; Hann S; Lin Y
    Curr Drug Targets; 2016; 17(8):853-64. PubMed ID: 25777274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
    Williamson DL; Bolster DR; Kimball SR; Jefferson LS
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E80-9. PubMed ID: 16760336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
    Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
    Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
    Zakikhani M; Dowling R; Fantus IG; Sonenberg N; Pollak M
    Cancer Res; 2006 Nov; 66(21):10269-73. PubMed ID: 17062558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells.
    Lee JO; Lee SK; Jung JH; Kim JH; You GY; Kim SJ; Park SH; Uhm KO; Kim HS
    J Cell Physiol; 2011 Apr; 226(4):974-81. PubMed ID: 20857458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy.
    Vazquez-Martin A; Oliveras-Ferraros C; del Barco S; Martin-Castillo B; Menendez JA
    Ann Oncol; 2009 Mar; 20(3):592-5. PubMed ID: 19153119
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.
    Kanazawa I; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
    Biochem Biophys Res Commun; 2008 Oct; 375(3):414-9. PubMed ID: 18721796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermidine may decrease ER stress in pancreatic beta cells and may reduce apoptosis via activating AMPK dependent autophagy pathway.
    Tirupathi Pichiah PB; Suriyakalaa U; Kamalakkannan S; Kokilavani P; Kalaiselvi S; SankarGanesh D; Gowri J; Archunan G; Cha YS; Achiraman S
    Med Hypotheses; 2011 Oct; 77(4):677-9. PubMed ID: 21831529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways.
    Chiang PC; Lin SC; Pan SL; Kuo CH; Tsai IL; Kuo MT; Wen WC; Chen P; Guh JH
    Biochem Pharmacol; 2010 Jan; 79(2):162-71. PubMed ID: 19723512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.